日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A VLP-based immunogen that elicits selective anti-Myostatin antibodies, enhances muscle mass and strength, and reduces adiposity

一种基于病毒样颗粒(VLP)的免疫原,可诱导产生选择性抗肌肉生长抑制素抗体,增强肌肉质量和力量,并减少脂肪堆积。

Jacquez, Quiteria; Peabody, Julianne; Acosta, Eduardo Hernandez; Chackerian, Bryce; Endicott, S Joseph

Targeting of phosphorylated tau at threonine 181 by a Qβ virus-like particle vaccine is safe, highly immunogenic, and reduces disease severity in mice and rhesus macaques.

通过 Qβ 病毒样颗粒疫苗靶向苏氨酸 181 处的磷酸化 tau 蛋白,是安全的,具有高度免疫原性,并能降低小鼠和恒河猴的疾病严重程度

Maphis Nicole M, Hulse Jonathan, Peabody Julianne, Dadras Somayeh, Whelpley Madelin J, Kandath Manas, Wilson Colin, Hobson Sasha, Thompson Jeff, Poolsup Suttinee, Beckman Danielle, Ott Sean P, Watanabe Jennifer W, Usachenko Jodie L, Van Rompay Koen K, Morrison John, Selwyn Reed, Rosenberg Gary, Knoefel Janice, Chackerian Bryce, Bhaskar Kiran

Two doses of Qβ virus like particle vaccines elicit protective antibodies against heroin and fentanyl

两剂Qβ病毒样颗粒疫苗可诱导产生针对海洛因和芬太尼的保护性抗体。

Romano, Isabella G; Johnson-Weaver, Brandi; Core, Susan B; Jamus, Andzoa N; Brackeen, Marcus; Blough, Bruce; Dey, Subhakar; Huang, Yumei; Staats, Herman; Wetsel, William C; Chackerian, Bryce; Frietze, Kathryn M

pS396/pS404 (PHF1) tau vaccine outperforms pS199/pS202 (AT8) in rTg4510 tauopathy model.

在 rTg4510 tau 病模型中,pS396/pS404 (PHF1) tau 疫苗优于 pS199/pS202 (AT8)

Hulse Jonathan P, Maphis Nicole M, Peabody Julianne, Bondu Virginie, Chackerian Bryce, Bhaskar Kiran

Formulation, Characterization, and In Vivo Immunogenicity of Heat-Stabilized Dissolvable Microneedles Containing a Novel VLP Vaccine

新型病毒样颗粒疫苗的热稳定可溶性微针的制备、表征及体内免疫原性研究

Leyba, Aidan; Francian, Alexandra; Razjmoo, Mohammad; Bierle, Amelia; Janardhana, Ranjith; Jackson, Nathan; Chackerian, Bryce; Muttil, Pavan

Superior Potency of Synthetic Virus-like Structures in Vaccine-Induced Antibody Responses Compared to Qβ Bacteriophage Virus-like Particles.

与 Qβ 噬菌体病毒样颗粒相比,合成病毒样结构在疫苗诱导的抗体反应中具有更强的效力

Meyer Alexander R, Li Libo, Wholey Wei-Yun, Chackerian Bryce, Cheng Wei

Virus-like particle-based vaccines targeting the Anopheles mosquito salivary protein TRIO

靶向按蚊唾液蛋白TRIO的病毒样颗粒疫苗

Francian, Alexandra; Flores-Garcia, Yevel; Powell, John R; Petrovsky, Nikolai; Zavala, Fidel; Chackerian, Bryce

Multi-phase Training in Virus-Like Particle Synthesis to Foster Science Self-efficacy in Students With Minimal Laboratory Experience.

针对实验室经验较少的学生,开展病毒样颗粒合成多阶段培训,以培养其科学自主能力

Proctor-Roser Macie A, Faimau Marinca, Peabody Julianne, Charley Krystal R, Chackerian Bryce, Lee Naomi R

Pathological tau activates inflammatory nuclear factor-kappa B (NF-κB) and pT181-Qβ vaccine attenuates NF-κB in PS19 tauopathy mice

病理性tau蛋白激活炎症性核因子-κB (NF-κB),而pT181-Qβ疫苗可减弱PS19 tau蛋白病小鼠中的NF-κB活性。

Tangavelou, Karthikeyan; Jiang, Shanya; Dadras, Somayeh; Hulse, Jonathan P; Sanchez, Kathryn; Bondu, Virginie; Villaseñor, Zachary; Mandell, Michael; Peabody, Julianne; Chackerian, Bryce; Bhaskar, Kiran

A Comparative Evaluation of Adjuvants for Enhancing Antibody Responses to a Nanoparticle-Based Malaria Vaccine

增强纳米颗粒疟疾疫苗抗体反应的佐剂比较评价

Nepal, Yogesh; Francian, Alexandra; Roberts, Bryce T; Khan, Rabia; Wondra, Garrett; Demierre, Aurélie; Apel, Falko; Chackerian, Bryce